Tay-Sachs disease is a rare, inherited disease. It is a type of lipid metabolism disorder. It causes too much of a fatty substance to build up in the brain. This buildup destroys nerve cells, causing mental and physical problems.
Infants with Tay-Sachs disease appear to develop normally for the first few months of life. Then mental and physical abilities decline. The child becomes blind, deaf, and unable to swallow. Muscles begin to waste away and paralysis sets in. Even with the best of care, children with Tay-Sachs disease usually die by age 4.
The cause is a gene mutation which is most common in Eastern European Ashkenazi Jews. To get the disease, both parents must have the gene. If they do, there is a 25% chance of the child having the disease. A blood test and prenatal tests can check for the gene or the disease.
There is no cure. Medicines and good nutrition can help some symptoms. Some children need feeding tubes.
NIH: National Institute of Neurological Disorders and Stroke
- Lipid Storage Diseases (National Institute of Neurological Disorders and Stroke)
- Sandhoff Disease (National Institute of Neurological Disorders and Stroke)
- GM2-gangliosidosis, AB variant: MedlinePlus Genetics (National Library of Medicine)
- Sandhoff disease: MedlinePlus Genetics (National Library of Medicine)
- Tay-Sachs disease: MedlinePlus Genetics (National Library of Medicine)
- ClinicalTrials.gov: Tay-Sachs Disease (National Institutes of Health)
Journal Articles References and abstracts from MEDLINE/PubMed (National Library of Medicine)
- Article: Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated...
- Article: Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2...
- Article: Biochemical and mutational analyses of HEXA in a cohort of Egyptian...
- Tay-Sachs Disease -- see more articles